Kolon Life Science Inc.
102940.KQ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$162.45B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $162.45 Billion |
|---|---|
| Enterprise Value | $292.29 Billion |
| Earnings per Share | $2001 |
| Beta | 0.43 |
| Outstanding Shares | 13,091,000 |
Return
| Return on Equity | 4.97% |
|---|---|
| Return on Assets | 3.19% |
| Return on Invested Capital | 2.84% |
Valuation & Multiples
| P/E Ratio | 4.52 |
|---|---|
| PEG | 9.6 |
| Price to Sales | 0.81 |
| Price to Book Ratio | 0.24 |
| Enterprise Value to Revenue | 1.38 |
| Enterprise Value to EBIT | 11.73 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0.55 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Kolon Life Science Inc.
432 employees
CEO: Seon-Jin Kim
Kolon Life Science Inc. is primarily engaged in the creation and distribution of pharmaceutical products and environmental materials. The company's operations are organized into two distinct units: Chemical and Bio. Its Chemical division...